Our mission is very straightforward: eliminate the burden of cancer. Our team of more than 160 world-class researchers and clinicians are raising cancer research, drug development and delivery, prevention and survivorship, and patient care to a higher standard, with one goal in mind: defeating cancer.
Nanotax: The University of Kansas Cancer Center is currently enrolling patients in this Phase I Clinical Trial.
Click here to learn more.
Led by Scott Weir, PharmD, PhD, the Institute focuses on the discovery and commercialization of medical innovations, and training the next generation of translational scientists. Applications are currently being accepted for proof of concept funding. To view and/or download a copy of the RFP, application form and review criteria, go to http://www2.kumc.edu/iami/
Purchase Your Driven to Cure License Plate Today
©
The University of Kansas Medical Center
